ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987